Corcept Therapeutics CORT
NASDAQ CORT
$111.62 -1.18 (-1.05%)
As of: Sep 4, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Property, Plant & Equipment (Net) (2010 - 2026)

Analysis

Corcept Therapeutics (CORT) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Corcept Therapeutics 11.76 Bn 11.46 Bn 252.09 Mn 5.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.13 Mn
Mar 31, 2026 3.17 Mn
Dec 31, 2025 1.89 Mn
Sep 30, 2025 2.09 Mn
Jun 30, 2025 2.35 Mn
Mar 31, 2025 2.54 Mn
Dec 31, 2024 2.69 Mn
Sep 30, 2024 2.93 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 127,000.00
Dec 31, 2023 195,000.00
Sep 30, 2023 302,000.00
Jun 30, 2023 413,000.00
Mar 31, 2023 461,000.00
Dec 31, 2022 633,000.00
Sep 30, 2022 801,000.00
Jun 30, 2022 862,000.00
Mar 31, 2022 726,000.00
Dec 31, 2021 1.00 Mn
Sep 30, 2021 1.23 Mn